Normalization Of Postreatment SCC Ag As A Prognostic Marker In Patients With Advanced Cervical Cancer Treated With First-Line Bevacizumab-Paclitaxel-Cisplatin Therapy
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0
제목
Normalization Of Postreatment SCC Ag As A Prognostic Marker In Patients With Advanced Cervical Cancer Treated With First-Line Bevacizumab-Paclitaxel-Cisplatin Therapy
저자
Song, Haa-Na
DOI
10.1016/j.ijgc.2024.100453
발행일
2025-02
유형
Meeting Abstract
저널명
International Journal of Gynecological Cancer
35
2